1. Home
  2. Our Firm
  3. News
  4. Michael Schmidt to Join Guggenheim Securities as Biotech Analyst

Our Firm

March 19, 2018

Michael Schmidt to Join Guggenheim Securities as Biotech Analyst

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Michael Schmidt, Ph.D. will join the firm in June as a Senior Analyst and Senior Managing Director in a planned expansion of the firm’s Healthcare Research team. Dr. Schmidt will focus on the coverage of Biotech companies, working closely with our growing therapeutics team.

Dr. Schmidt will join Guggenheim from LEERINK Partners, where he has been an equity research analyst since 2009 and was named runner-up in the 2017 Institutional Investor All-America Research Survey in the Biotech/Mid- & Small-Cap category. Previous to joining LEERINK in 2009, he was a healthcare analyst and consultant for Susquehanna International Group’s private equity team. Dr. Schmidt was a research fellow at Harvard University previous to his work at Susquehanna.

“We are excited to have Michael join our growing healthcare equity research team,” said Stefano Natella, Director of Equity Research. “He represents an important next step in our plan to invest substantially in our research capabilities, particularly in the healthcare sector. We look forward to his continued success at Guggenheim.”

Michael Schmidt received his Ph.D. and M.Sc. from the University of Stuttgart in biochemistry and molecular genetics, respectively.


About Guggenheim Securities

Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, Los Angeles, San Francisco, and Houston. For more information, please contact us at GSinfo@GuggenheimPartners.com or 212.518.9200.

About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $305 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With more than 2,300 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.


Media Contact

Ellen Cunningham
Guggenheim Partners
212.518.9578
Ellen.N.Cunningham@GuggenheimPartners.com

 

1Assets under management are as of 12.31.2017 and include consulting services for clients whose assets are valued at approximately $66bn.



January 04, 2021

Guggenheim Securities Hires Simon Mullaly to Expand Credit Trading Capabilities

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Simon Mullaly has joined the firm as a Managing Director to expand its fixed income credit trading capabilities.

Read More

December 17, 2020

Guggenheim Partners Selects Third Cohort of Network for Social Innovation

NEW YORK, NY – Guggenheim Partners is proud to announce the selection of five non-profit organizations for the third cohort of the Network for Social Innovation.

Read More

December 04, 2020

Guggenheim Securities Hires Michael Amez to Expand Middle Market Investment Banking Practice

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Michael Amez has joined the firm as a Senior Managing Director to expand its middle market investment banking coverage and will focus on advising companies in the technology sector.

Read More



© 2021 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.